Compound Detail
CHEMBL494089
GSK-690693 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL494089 |
| Name | GSK-690693 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | KGPGFQWBCSZGEL-ZDUSSCGKSA-N |
100
Targets
176
Activities
3
Assay Types
12
PK Parameters
20
Publications
3
Known Names
1
Indications
3
Mechanisms
Molecular Properties
425.5
MW (Da)
1.58
ALogP
10
HBA
3
HBD
137.1
PSA (Ų)
0.52
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase AKT inhibitor | INHIBITOR | Serine/threonine-protein kinase AKT | ✓ | ✓ |
| cAMP-dependent protein kinase (PKA) inhibitor | INHIBITOR | cAMP-dependent protein kinase (PKA) | ✓ | ✓ |
| Protein kinase C (PKC) inhibitor | INHIBITOR | Protein kinase C (PKC) | ✓ | ✓ |
Indications
Neoplasms
Activity Summary
Kd 110 meas. best 8.68
IC50 61 meas. best 9.22
Ki 5 meas. best 9.0
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 3150.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2010.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 3250.0 | ng.hr.mL-1 | Macaca mulatta |
| CL | 56.7 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 34.6 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 22.5 | mL.min-1.kg-1 | Macaca mulatta |
| Cmax | 5005.99 | nM | Rattus norvegicus |
| Cmax | 3055.3 | nM | Canis lupus familiaris |
| Cmax | 3525.35 | nM | Macaca mulatta |
| T1/2 | 8.92 | hr | Rattus norvegicus |
| T1/2 | 3.5 | hr | Canis lupus familiaris |
| T1/2 | 5.52 | hr | Macaca mulatta |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22037378 | 10.1038/nbt.1990 | Tyrosine-protein kinase ABL1 | 15 |
| 22037378 | 10.1038/nbt.1990 | Epidermal growth factor receptor | 12 |
| 39047611 | 10.1016/j.ejmech.2024.116698 | A549 | 10 |
| 22037378 | 10.1038/nbt.1990 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| 26254279 | 10.18632/oncotarget.4214 | Serine/threonine-protein kinase AKT | 9 |
| 22037378 | 10.1038/nbt.1990 | Mast/stem cell growth factor receptor Kit | 8 |
| 22037378 | 10.1038/nbt.1990 | Receptor-type tyrosine-protein kinase FLT3 | 7 |
| 18800763 | 10.1021/jm8004527 | Rhesus monkey | 5 |
| 30151089 | 10.1039/C8MD00197A | RAC-alpha serine/threonine-protein kinase | 5 |
| 18800763 | 10.1021/jm8004527 | Canis familiaris | 5 |
| 18800763 | 10.1021/jm8004527 | Rattus norvegicus | 5 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| 18800763 | 10.1021/jm8004527 | Mus musculus | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 22037378 | 10.1038/nbt.1990 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| 18800763 | 10.1021/jm8004527 | RAC-alpha serine/threonine-protein kinase | 4 |
| 18800763 | 10.1021/jm8004527 | RAC-beta serine/threonine-protein kinase | 3 |
| 22037378 | 10.1038/nbt.1990 | Hepatocyte growth factor receptor | 3 |
| 28704757 | 10.1016/j.ejmech.2017.06.067 | Unchecked | 3 |
| 22037378 | 10.1038/nbt.1990 | Ribosomal protein S6 kinase alpha-4 | 2 |
Data from ChEMBL 36 via Core Engine